Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution
- 1 February 2006
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 100 (2) , 609-614
- https://doi.org/10.1152/japplphysiol.00797.2005
Abstract
The human immunodeficiency virus (HIV)-lipodystrophy syndrome is associated with fat redistribution and metabolic abnormalities, including insulin resistance. Increased intramyocellular lipid (IMCL) concentrations are thought to contribute to insulin resistance, being linked to metabolic and body composition variables. We examined 46 women: HIV infected with fat redistribution ( n = 25), and age- and body mass index-matched HIV-negative controls ( n = 21). IMCL was measured by1H-magnetic resonance spectroscopy, and body composition was assessed with computed tomography, dual-energy X-ray absorptiometry (DEXA), and magnetic resonance imaging. Plasma lipid profile and markers of glucose homeostasis were obtained. IMCL was significantly increased in tibialis anterior [135.0 ± 11.5 vs. 85.1 ± 13.2 institutional units (IU); P = 0.007] and soleus [643.7 ± 61.0 vs. 443.6 ± 47.2 IU, P = 0.017] of HIV-infected subjects compared with controls. Among HIV-infected subjects, calf subcutaneous fat area (17.8 ± 2.3 vs. 35.0 ± 2.5 cm2, P < 0.0001) and extremity fat by DEXA (11.8 ± 1.1 vs. 15.6 ± 1.2 kg, P = 0.024) were reduced, whereas visceral abdominal fat (125.2 ± 11.3 vs. 74.4 ± 12.3 cm2, P = 0.004), triglycerides (131.1 ± 11.0 vs. 66.3 ± 12.3 mg/dl, P = 0.0003), and fasting insulin (10.8 ± 0.9 vs. 7.0 ± 0.9 μIU/ml, P = 0.004) were increased compared with control subjects. Triglycerides ( r = 0.39, P = 0.05) and extremity fat as percentage of whole body fat by DEXA ( r = −0.51, P = 0.01) correlated significantly with IMCL in the HIV but not the control group. Extremity fat (β = −633.53, P = 0.03) remained significantly associated with IMCL among HIV-infected patients, controlling for visceral abdominal fat, abdominal subcutaneous fat, and antiretroviral medications in a regression model. These data demonstrate increased IMCL in HIV-infected women with a mixed lipodystrophy pattern, being most significantly associated with reduced extremity fat. Further studies are necessary to determine the relationship between extremity fat loss and increased IMCL in HIV-infected women.Keywords
This publication has 24 references indexed in Scilit:
- Intramyocellular Lipid Quantification: Repeatability with1H MR SpectroscopyRadiology, 2005
- Differential Effects of Metformin and Exercise on Muscle Adiposity and Metabolic Indices in Human Immunodeficiency Virus-Infected PatientsJournal of Clinical Endocrinology & Metabolism, 2004
- Cellular mechanism of insulin resistance: potential links with inflammationInternational Journal of Obesity, 2003
- Insulin Action, Regional Fat, and Myocyte Lipid: Altered Relationships with Increased AdiposityObesity Research, 2003
- Gender Differences in Antiretroviral Drug–Related Adipose Tissue AlterationsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Enzyme activities in the tibialis anterior muscle of young moderately active men and women: relationship with body composition, muscle cross‐sectional area and fibre type compositionActa Physiologica Scandinavica, 2002
- Metabolic basis of HIV-lipodystrophy syndromeAmerican Journal of Physiology-Endocrinology and Metabolism, 2002
- Association of Severe Insulin Resistance With Both Loss of Limb Fat and Elevated Serum Tumor Necrosis Factor Receptor Levels in HIV LipodystrophyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Association of Severe Insulin Resistance With Both Loss of Limb Fat and Elevated Serum Tumor Necrosis Factor Receptor Levels in HIV LipodystrophyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudineAIDS, 1998